Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2024
Emergence of IGH::CCND1 Rearrangement and Mutations in TP53, BTK, and BCL2 Associated With Therapy Resistance in Chronic Lymphocytic Leukemia, Qing Wei, Hong Fang, James M Jing, et al.
Detection of KMT2A Partial Tandem Duplication by Optical Genome Mapping in Myeloid Neoplasms: Associated Cytogenetics, Gene Mutations, Treatment Responses, and Patient Outcomes, Qing Wei, Shimin Hu, Jie Xu, et al.
Diagnostic Utility of Immunohistochemistry in Detection of NPM1 Mutations in Acute Myeloid Leukemia With a Patchy Distribution, Qing Wei, Sa A Wang, Sanam Loghavi, et al.
Chronic Eosinophilic Leukemia With a Novel JAK1 Mutation Responds Well to the JAK1/2 Inhibitor Ruxolitinib, Qing Wei and Jie Xu
AEL Transformed From Post-ET Myelofibrosis With a Sinusoidal Pattern, JAK2 Mutation, and Biallelic TP53 Inactivation, Qing Wei and M James You
Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy, Annikka Weissferdt, Cheuk H Leung, Heather Lin, et al.
Downregulation of UBA1 Expression in Myelodysplastic Neoplasm, Yue Wei, Hong Zheng, Ziyi Li, et al.
Minimal Information for Studies of Extracellular Vesicles (MISEV2023): From Basic to Advanced Approaches, Joshua A Welsh, Deborah C I Goberdhan, Lorraine O'Driscoll, et al.
Optimizing Outpatient Radiation Oncology Consult Workflow by Using Time-Driven Activity-Based Costing: Efficiency and Financial Impacts, Julius Weng, Shane Mesko, Gregory Chronowski, et al.
Editorial: Advances and Methods in Mesenchymal Stem Cells, Pamela L Wenzel
Deep Learning-Based H-Score Quantification of Immunohistochemistry-Stained Images, Zhuoyu Wen, Danni Luo, Shidan Wang, et al.
First-in-Human Dose Escalation Trial To Evaluate the Clinical Safety and Efficacy of an Anti-MAGEA1 Autologous Tcr-Transgenic T Cell Therapy in Relapsed and Refractory Solid Tumors, Martin Wermke, Tobias A W Holderried, Jason John Luke, et al.
Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy, Jasmijn M Westerhoff, Lois A Daamen, John P Christodouleas, et al.
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial, Shannon N Westin, Kathleen Moore, Hye Sook Chon, et al.
Simulation-Based Caregiving Skills Training for Family Members of High-Grade Glioma Patients, Meagan Whisenant, Shiao-Pei Weathers, Yisheng Li, et al.
A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis, Brian S White, Xing Yi Woo, Soner Koc, et al.
A First-in-Class Selective Inhibitor of Egfr and PI3K Offers a Single-Molecule Approach to Targeting Adaptive Resistance, Christopher E Whitehead, Elizabeth K Ziemke, Christy L Frankowski-McGregor, et al.
Unexpected Inhibition of the Lipid Kinase PIKfyve Reveals an Epistatic Role for P38 MAPKs in Endolysosomal Fission and Volume Control, Daric J Wible, Zalak Parikh, Eun Jeong Cho, et al.
Leptomeningeal Metastases From Solid Tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology Consensus Review on Clinical Management and Future Directions, Jessica A Wilcox, Ugonma N Chukwueke, Myung-Ju Ahn, et al.
Cascade Genetic Testing: An Underutilized Pathway to Equitable Cancer Care?, Roni Nitecki Wilke, Erica M Bednar, Sara Pirzadeh-Miller, et al.
Cascade Genetic Testing: An Underutilized Pathway to Equitable Cancer Care?, Roni Nitecki Wilke, Erica M Bednar, Sara Pirzadeh-Miller, et al.
Impact of Isotype on the Mechanism of Action of Agonist Anti-OX40 Antibodies in Cancer: Implications for Therapeutic Combinations, Jane E Willoughby, Lang Dou, Sabyasachi Bhattacharya, et al.
Rehabilitation Treatment Specification System for Voice Therapy: Application to Everyday Clinical Care, Jeremy Wolfberg, John Whyte, Patricia Doyle, et al.
Multidisciplinary Prehabilitation To Improve Frailty and Functional Capacity in High-Risk Elective Surgical Patients: A Retrospective Pilot Study, Henry Man Kin Wong, Ding Qi, Bosco Hon Ming Ma, et al.
Innovations in Molecular Biomarkers and Biomaterial-Based Immunotherapies for Head & Neck Cancer, Sarah Anne Wong, Victoria A Manon, Simon Young, et al.